Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Tomohiro HOSOYA"'
Autor:
Tomohiro Hosoya, Atsushi Kambe, Irfan Kesumayadi, Karen Makishima, Shuntaro Sueyoshi, Makoto Sakamoto, Masamichi Kurosaki
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract In this study, we focused on calcification and diffusion restriction, which sometimes appear around the resection cavity or periventricular white matter in patients with high-grade glioma (HGG) treated with bevacizumab (BVZ), as candidate im
Externí odkaz:
https://doaj.org/article/aa13a6b63e2b4760a2c9b046e2466350
Autor:
Kenji Yoshida, Tomoyuki Akita, Kosuke Katayama, Kiyohide Kakuta, Takafumi Nishizaki, Fumiyuki Yamasaki, Hirotaka Fudaba, Kenichiro Asano, Takashi Sasayama, Manabu Natsumeda, Taichi Shimabukuro, Kotaro Taguchi, Shinichiro Koizumi, Noriyuki Nakayama, Kentaro Fujii, Ikuno Nishibuchi, Kazuhiko Sugiyama, Ushio Yonezawa, Momii Yasutomo, Yukari Kawasaki, Kazuhiro Tanaka, Hiroaki Nagashima, Yoshihiro Tsukamoto, Makoto Ideguchi, Kazuhiko Kurozumi, Tomohiro Hosoya, Atsushi Kambe
Publikováno v:
BMJ Open, Vol 13, Iss 4 (2023)
Introduction Multidrug chemoimmunotherapy with rituximab, high-dose methotrexate, procarbazine and vincristine (R-MPV) is a standard therapy for younger patients with primary central nervous system lymphoma (PCNSL); however, prospective data regardin
Externí odkaz:
https://doaj.org/article/19a3f93622fa498a96c3eec56dc02310
Autor:
Tomohiro Hosoya, Masamichi Takahashi, Calvin Davey, Jun Sese, Mai Honda-Kitahara, Yasuji Miyakita, Makoto Ohno, Shunsuke Yanagisawa, Takaki Omura, Daisuke Kawauchi, Yukie Ozeki, Miyu Kikuchi, Tomoyuki Nakano, Akihiko Yoshida, Hiroshi Igaki, Yuko Matsushita, Koichi Ichimura, Yoshitaka Narita
Publikováno v:
Biomolecules, Vol 12, Iss 10, p 1379 (2022)
The aim of the present study was to determine which individual or combined CpG sites among O6-methylguanine DNA methyltransferase CpG 74–89 in glioblastoma mainly affects the response to temozolomide resulting from CpG methylation using statistical
Externí odkaz:
https://doaj.org/article/b3d3b004e156448c896aaac5b70f88ae
Publikováno v:
Yonago Acta Medica; 2023, Vol. 66 Issue 3, p385-388, 4p
Autor:
Tomohiro Hosoya, Masamichi Takahashi, Mai Honda-Kitahara, Yasuji Miyakita, Makoto Ohno, Shunsuke Yanagisawa, Takaki Omura, Daisuke Kawauchi, Yukie Tamura, Miyu Kikuchi, Tomoyuki Nakano, Akihiko Yoshida, Hiroshi Igaki, Yuko Matsushita, Koichi Ichimura, Yoshitaka Narita
Publikováno v:
Journal of Neuro-Oncology. 157:561-571
Purpose Although the usefulness of O6-methylguanine DNA methyltransferase (MGMT) promoter methylation analysis for predicting response to chemoradiotherapy and the prognosis of patients with glioblastoma has been widely reported, there is still no co
Autor:
Makoto SAKAMOTO, Tetsuji UNO, Sadao NAKAJIMA, Tomohiro HOSOYA, Yuhei KUWAMOTO, Syuntarou SUEYOSHI, Atsushi KAMBE, Masamichi KUROSAKI
Publikováno v:
Surgery for Cerebral Stroke. 50:482-491
Autor:
Maya Yamashita, Ken Ukibe, Yumi Matsubara, Tomohiro Hosoya, Fumihiko Sakai, Shigeyuki Kon, Yasunobu Arima, Masaaki Murakami, Hisako Nakagawa, Tadaaki Miyazaki
Publikováno v:
Frontiers in Microbiology, Vol 8 (2018)
We recently reported that Lactobacillus helveticus SBT2171 (LH2171) inhibited the proliferation and inflammatory cytokine production of primary immune cells in vitro, and alleviated collagen-induced arthritis (CIA) in mice, a model of human rheumatoi
Externí odkaz:
https://doaj.org/article/2469ffbd040540fbaf904e3d1282a424
Autor:
Maya Yamashita, Kurumi Matsumoto, Tsutomu Endo, Ken Ukibe, Tomohiro Hosoya, Yumi Matsubara, Hisako Nakagawa, Fumihiko Sakai, Tadaaki Miyazaki
Publikováno v:
Frontiers in Microbiology, Vol 8 (2017)
We recently reported that the intraperitoneal inoculation of Lactobacillus helveticus SBT2171 inhibited the development of collagen-induced arthritis (CIA), a murine model of rheumatoid arthritis (RA). In the present study, we evaluated the effect of
Externí odkaz:
https://doaj.org/article/144afa1546184efe8b36d2948fe71cd4
Autor:
Fumiyuki Yamasaki, Hirotaka Fudaba, Kenichiro Asano, Takashi Sasayama, Manabu Natsumeda, Taichi Shimabukuro, Kotaro Taguchi, Shinichiro Koizumi, Noriyuki Nakayama, Kentaro Fujii, Ikuno Nishibuchi, Kazuhiko Sugiyama, Kenji Yoshida, Ushio Yonezawa, Momii Yasutomo, Yukari Kawasaki, Kiyohide Kakuta, Kosuke Katayama, Kazuhiro Tanaka, Hiroaki Nagashima, Yoshihiro Tsukamoto, Makoto Ideguchi, Takafumi Nishizaki, Kazuhiko Kurozumi, Tomohiro Hosoya, Tomoyuki Akita, Atsushi Kambe
Publikováno v:
BMJ Open. 13:e071350
IntroductionMultidrug chemoimmunotherapy with rituximab, high-dose methotrexate, procarbazine and vincristine (R-MPV) is a standard therapy for younger patients with primary central nervous system lymphoma (PCNSL); however, prospective data regarding
Autor:
Takaki Omura, Masamichi Takahashi, Makoto Ohno, Yasuji Miyakita, Shunsuke Yanagisawa, Yukie Tamura, Miyu Kikuchi, Daisuke Kawauchi, Tomoyuki Nakano, Tomohiro Hosoya, Hiroshi Igaki, Kaishi Satomi, Akihiko Yoshida, Kuniko Sunami, Makoto Hirata, Tatsunori Shimoi, Kazuki Sudo, Hitomi S. Okuma, Kan Yonemori, Hiromichi Suzuki, Koichi Ichimura, Yoshitaka Narita
Publikováno v:
Cancers; Volume 14; Issue 10; Pages: 2454
Next-generation sequencing-based comprehensive genomic profiling test (CGPT) enables clinicians and patients to access promising molecularly targeted therapeutic agents. Approximately 10% of patients who undergo CGPT receive an appropriate agent. How